MedPath

The effect of zinc sulfate on plasma adiponectin and insulin resistance in first-degree relatives of diabetic patients

Phase 2
Conditions
First gegree Relatives of Diabetic Patients.
Diabetes mellitus
E10, E11,
Registration Number
IRCT138811253312N2
Lead Sponsor
Yazd Diabetes Research Center, Shahid Sadoughi Univercity of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
70
Inclusion Criteria

First-degree relatives of diabetic patients with BMI >25kg/m2 and age>25 years Exclusion criteria: Diabetic patients or first degree relatives with BMI=<25kg/m2 or who consumed Vit D or Magnesium supplementation for past three months

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Insulin. Timepoint: Before intervention and 12 weeks after intervention. Method of measurement: inSulin Kit and the Unit is mu/lit.;Adiponectin. Timepoint: Before intervention and 12 weeks after intervention. Method of measurement: Adiponectin kit and the unit is ng/ml.
Secondary Outcome Measures
NameTimeMethod
FBS. Timepoint: 12 weeks. Method of measurement: Measurement of blood glucose by Auto nalyser method.;2hpp. Timepoint: 12 weeks. Method of measurement: Measurement of blood glucose by Auto nalyser method.;TG. Timepoint: 12 weeks. Method of measurement: Measurement of triglyceride by Auto Analyser method.;Cholesterol. Timepoint: 12 weeks. Method of measurement: Measurement of cholestrol by Auto nalyser method.;HDL. Timepoint: 12 weeks. Method of measurement: Measurement of HDL by Auto Analyser method.;LDL. Timepoint: 12 weeks. Method of measurement: Measurement of LDL by Auto Analyser method.
© Copyright 2025. All Rights Reserved by MedPath